KKR Closes $2.1 Billion Loan for Integer Holdings Acquisition

KKR & Co. Inc. finalized a $2.1 billion leveraged loan on March 19, 2024, to support its pending acquisition of Integer Holdings Corp., a medical-device manufacturer. This significant financing was secured by capitalizing on robust investor appetite for leveraged-buyout financings, indicating a favorable market for such deals. The loan's finalization demonstrates KKR's ability to navigate the debt markets effectively to fund its strategic acquisitions. Integer Holdings Corp. is a global medical device company that designs, develops, manufactures, and markets a wide range of medical devices and components. Its product portfolio includes cardiovascular, orthopedic, and other medical applications, serving both original equipment manufacturers and healthcare providers. The acquisition by KKR, a leading global investment firm, is expected to provide Integer Holdings with additional resources and strategic guidance to further its growth and innovation in the medical technology sector. The terms of the loan, while not fully detailed, were described as "more-favorable," suggesting that KKR was able to negotiate advantageous interest rates or other conditions due to strong demand from lenders and investors. This demand reflects a broader trend in the private equity market, where investors are actively seeking opportunities in leveraged-buyout financings, especially for companies with strong market positions and growth potential. Leveraged buyouts, or LBOs, involve the acquisition of another company using a significant amount of borrowed money (debt) to meet the cost of acquisition. The assets of the company being acquired are often used as collateral for the loans, along with the assets of the acquiring company. KKR, founded in 1976, is one of the world's largest alternative investment firms, managing a variety of funds that invest in private equity, energy, infrastructure, real estate, credit, and hedge funds. The firm has a long history of successfully executing large-scale acquisitions and has a significant presence in the healthcare and medical technology sectors. The acquisition of Integer Holdings by KKR is anticipated to be completed in the second half of 2024, subject to customary closing conditions and regulatory approvals. This transaction underscores KKR's strategy of investing in companies poised for expansion and operational improvement, leveraging its financial expertise and operational capabilities to drive value creation. The successful syndication of the $2.1 billion loan highlights the confidence that financial institutions and investors have in KKR's investment strategy and the future prospects of Integer Holdings.